Sun Pharma Advanced Research Company Limited (SPARC) — deviation variation | 10 August 2026

10 August 2026 · NSE 🟡 Notable Neutral

By StockFin Research Team•AI-Assisted Analysis•Source: BSE/NSE Filings

📢 Key Event

Monitoring Agency Report confirms no deviation in fund utilization for SPARC's preferential issue.

💡 Investor Takeaway

Investors should note that fund utilization aligns with disclosures, indicating no material risks or changes in the planned use of proceeds.

The Monitoring Agency Report confirms no deviation in the utilization of proceeds from SPARC's preferential issue of convertible warrants. The full ₹150 crores raised was used for working capital loan repayment, with no changes to planned utilization or material deviations observed. The report validates compliance with offer document disclosures and regulatory requirements.

📄 View Original Announcement (PDF)

📊 Stock Analysis — SPARC ✨ Ask AI About This

About Sun Pharma Advanced Research Company Limited (SPARC)

Healthcare · Pharmaceuticals · Listed on NSE

Market Cap: ₹6,774.39 CrP/E: 4.3ROE: 118.3%ROCE: 85.5%

View full SPARC stock details →

📡 Get AI alerts when SPARC files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track SPARC — Free

💡 Ask AI about this filing

"How does the full repayment of Kotak Mahindra loan impact SPARC's working capital position?""What is the expected timeline for R&D spending from the remaining issue proceeds?""How does this utilization compare to peers' preferential issue fund deployment patterns?"

Ask AI Free →

📊 More SPARC filings

Announcement — 25 September 2026Sun Pharma Advanced Research Company Ltd (SPARC) has announced that its trading window will close on...
Announcement — 13 August 2026Sun Pharma Advanced Research Company Limited (SPARC) has formally submitted an application to stock ...
🔴 Annual Report — 6 July 2026Sun Pharma Advanced Research Company Limited announced its 21st Annual General Meeting will be held ...
share transfer — 6 July 2026Sun Pharma Advanced Research Company Limited (SPARC) received confirmation certificates from its sha...
Announcement — 26 June 2026Sun Pharma Advanced Research Company Limited announced the retirement of Ms. Shanta Gupta and Dr. Ni...

See all SPARC filings →

🔥 Also filed on 10 August 2026

TIMKENTimken India LimitedFinancial Results DOMSDOMS Industries LimitedCorporate Action HGSHinduja Global Solutions LimitedFinancial Results SUNDRMFASTSundram Fasteners LimitedFinancial Results AMJLANDAmj Land Holdings LimitedAnnual Report KANSAINERKansai Nerolac Paints LimitedFinancial Results

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when SPARC files new disclosures

Track SPARC filings, board meetings, and corporate actions. Free email alerts at 5 PM.